Cargando…
Knockdown of nuclear receptor binding SET domain-containing protein 1 (NSD1) inhibits proliferation and facilitates apoptosis in paclitaxel-resistant breast cancer cells via inactivating the Wnt/β-catenin signaling pathway
The burden of breast cancer (BC) has exacerbated over decades. Paclitaxel resistance is responsible for increasing BC treatment burden. Nuclear receptor binding SET domain-containing protein 1 (NSD1) is positively correlated with a poor prognosis in patients with BC. This study investigates the func...
Autores principales: | Chen, Yi, Li, Xiao, Xu, Jin, Xiao, Hua, Tang, Cuiju, Liang, Wei, Zhu, Xuedan, Fang, Yueyu, Wang, Hanjin, Shi, Junfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973718/ https://www.ncbi.nlm.nih.gov/pubmed/35200072 http://dx.doi.org/10.1080/21655979.2021.2018973 |
Ejemplares similares
-
Nuclear receptor binding SET domain protein 1 promotes epithelial-mesenchymal transition in paclitaxel-resistant breast cancer cells via regulating nuclear factor kappa B and F-box and leucine-rich repeat protein 11
por: Chen, Yi, et al.
Publicado: (2021) -
In vitro histone lysine methylation by NSD1, NSD2/MMSET/WHSC1 and NSD3/WHSC1L
por: Morishita, Masayo, et al.
Publicado: (2014) -
KB-68A7.1 Inhibits Hepatocellular Carcinoma Development Through Binding to NSD1 and Suppressing Wnt/β-Catenin Signalling
por: Zhang, Shuhua, et al.
Publicado: (2022) -
CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway
por: Zhang, Shuhua, et al.
Publicado: (2019) -
CTB-193M12.5 Promotes Hepatocellular Carcinoma Progression via Enhancing NSD1-Mediated WNT10B/Wnt/β-Catenin Signaling Activation
por: Zhang, Shuhua, et al.
Publicado: (2022)